Piper Sandler Downgrades Soleno Therapeutics Inc. (SLNO) to Neutral
Tweet
Share
E-mailGet Alerts SLNO Hot Sheet
Price: $53.01 --0%
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 19
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 19
Join SI Premium – FREE
Piper Sandler analyst Yasmeen Rahimi downgraded Soleno Therapeutics Inc. (NASDAQ: SLNO) from Overweight to Neutral with a price target of $53.00 (from $145.00).
For an analyst ratings summary and ratings history on Soleno Therapeutics Inc. click here. For more ratings news on Soleno Therapeutics Inc. click here.
Shares of Soleno Therapeutics Inc. closed at $52.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Starts Rhythm Pharmaceuticals (RYTM) at Hold
- Goldman Sachs on Marvell (MRVL): 'We expect the stock to be range bound following results that were in line'
- WestPark Capital completes $940M Advasa direct listing on Nasdaq
Create E-mail Alert Related Categories
DowngradesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
